Compare POWL & PTCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | POWL | PTCT |
|---|---|---|
| Founded | 1947 | 1998 |
| Country | United States | United States |
| Employees | N/A | 991 |
| Industry | Electrical Products | Biotechnology: Pharmaceutical Preparations |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.6B | 5.4B |
| IPO Year | 1995 | 2006 |
| Metric | POWL | PTCT |
|---|---|---|
| Price | $192.18 | $65.79 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 4 | 17 |
| Target Price | ★ $184.25 | $80.65 |
| AVG Volume (30 Days) | 492.1K | ★ 813.5K |
| Earning Date | 05-04-2026 | 05-07-2026 |
| Dividend Yield | ★ 0.14% | N/A |
| EPS Growth | N/A | ★ 264.48 |
| EPS | ★ 3.81 | 0.90 |
| Revenue | ★ $448,716,000.00 | $264,734,000.00 |
| Revenue This Year | $11.20 | N/A |
| Revenue Next Year | $9.12 | $17.70 |
| P/E Ratio | ★ $49.23 | $72.51 |
| Revenue Growth | 13.34 | ★ 36.19 |
| 52 Week Low | $167.31 | $57.74 |
| 52 Week High | $612.50 | $90.87 |
| Indicator | POWL | PTCT |
|---|---|---|
| Relative Strength Index (RSI) | 49.53 | 38.95 |
| Support Level | $181.33 | $63.29 |
| Resistance Level | $219.27 | $74.30 |
| Average True Range (ATR) | 6.76 | 1.88 |
| MACD | 2.82 | -0.11 |
| Stochastic Oscillator | 92.65 | 13.13 |
Powell Industries Inc is a United States-based company that develops, designs, manufactures, and services custom-engineered equipment and systems for electrical energy distribution, control, and monitoring. The company's principal products comprise integrated power control room substations, custom-engineered modules, electrical houses, traditional and arc-resistant distribution switchgear and control gear, and so on. These products are applied in oil and gas refining, offshore oil and gas production, petrochemical, pipeline, terminal, mining and metals, light-rail traction power, electric utility, pulp and paper, and other heavy industrial markets. The company generates the majority of its sales from the United States, and the rest from Canada, Europe, Asia Pacific, and other regions.
PTC Therapeutics Inc is a biopharmaceutical company that discovers, develops and commercializes clinically differentiated medicines that provide benefits to children and adults living with rare disorders. Its diversified therapeutic portfolio that includes several commercial products and product candidates in various stages of development, including discovery, research and clinical stages, focused on the development of new treatments for multiple therapeutic areas for rare diseases relating to neurology and metabolism. The company views its operations and manages its business in one operating segment: life science, which is focused on the discovery, development and commercialization of the company's clinically differentiated medicines that provide benefits to patients with rare disorders.